Clinical, microbiologic, and outcome analysis of mycotic aortic aneurysm: the role of endovascular repair
- PMID: 24800865
- PMCID: PMC4063379
- DOI: 10.1089/sur.2013.011
Clinical, microbiologic, and outcome analysis of mycotic aortic aneurysm: the role of endovascular repair
Abstract
Background: Mycotic aortic aneurysm (MAA) is an infrequent but devastating form of vascular disease.
Methods: We conducted a retrospective cohort study at a major medical center to identify independent risk factors for MAA and to provide opinions about treating it. The study population consisted of 43 patients who had had 44 MAAs over a period of 15 y.
Results: All of the patients had positive blood cultures, radiologic findings typical of MAA, and clinical signs of infection (leukocytosis, fever, and elevated C-reactive protein). The mean age of the patients was 63.8±10.6 y and the mean period of their follow up was 35.7±39.3 mo. Twenty-nine patients with MAAs underwent traditional open surgery, 11 others received endovascular stent grafts, and four MAAs were managed conservatively. The most frequent causative pathogens were Salmonella (36/44 patients [81.8%]), in whom organisms of Salmonella serogroup C (consisting mainly of S. choleraesuis) were identified in 14 patients, organisms of Salmonella serogroup D were identified in 13 patients, and species without serogroup information were identified in nine patients. The overall mortality in the study population was 43.2% (with an aneurysm-related mortality of 18.2%, surgically related mortality of 13.6%, and in-hospital mortality of 22.7%).
Conclusions: Shock is a risk factor for operative mortality. Misdiagnosis and treatment of MAA as low back pain, co-existing connective-tissue disease such as systemic lupus erythematosus and rheumatoid arthritis, and Salmonella serogroup C-associated bacteremia are risk factors for aneurysm-related death. Endovascular repair should be considered as an alternative option to the open repair of MAA.
Figures
References
-
- Reddy DJ, Shepard AD, Evans JR, et al. . Management of infected aortoiliac aneurysms. Arch Surg 1991;126:873–878 - PubMed
-
- Baird RN. Mycotic aortic aneurysms. Eur J Vasc Surg 1989;3:95–96 - PubMed
-
- Fichelle JM, Tabet G, Cormier P, et al. . Infected infrarenal aortic aneurysms: When is in situ reconstruction safe? J Vasc Surg 1993;17:635–645 - PubMed
-
- Hsu RB, Tsay YG, Wang SS, Chu SH. Surgical treatment for primary infected aneurysm of the descending thoracic aorta, abdominal aorta, and iliac arteries. J Vasc Surg 2002;36:746–750 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
